Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid

Journal of Dermatological Science

Volumn 37, Issue 3, 2005, Pages 145-149

  Tsuji Abe, Yukiko ^a   Akiyama, Masashi ^a   Yamanaka, Yasuko ^a   Kikuchi, Toshiro ^a   Sato Matsumura, Kazuko C ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; BP; BPAG2; Indirect immunofluorescence; Steroid resistant

Indexed keywords

ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PEMPHIGOID; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 14744301980     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.10.007     Document Type: Article

References (13)

1. G.J. Giudice, D.J. Emery, B.D. Zelickson, G.J. Anhalt, Z. Liu, and L.A. Diaz Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain J Immunol 151 1993 5742 5750
2. D. Zillikens, J.M. Mascaro, P.A. Rose, Z. Liu, S.M. Ewing, and F. Caux A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid J Invest Dermatol 109 1997 679 683
3. C. Nakatani, T. Muramatsu, and T. Shirai Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins Br J Dermatol 139 1998 365 370
4. Y. Hata, Y. Fujii, K. Tsunoda, and M. Amagai Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression J Dermatol Sci 23 2000 183 190
5. E. Schmidt, K. Obe, E.B. Brocher, and D. Zillikens Serum levels of autoantibodies to BP180 correlate with diesase activity in patients with bullous pemphigoid Arch Dermatol 136 2000 174 178
6. Y. Amo, T. Ohkawa, M. Tatsuta, Y. Hamada, T. Fujimura, and K. Katsuoka Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid J Dermatol Sci 26 2001 14 18
7. M. Kobayashi, M. Amagai, K. Kuroda-Kinoshita, T. Hashimoto, Y. Shirakata, and K. Hashimoto BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid J Deramtol Sci 30 2002 224 232
8. E.H. Beutner, R.E. Jordon, and T.P. Chorzelski The immunopathology of pemphigus and bullous pemphigoid J Invest Dermatol 51 1968 63 80
9. A. Ishiko, H. Shimizu, A. Kikuchi, T. Ebihara, T. Hashimoto, and T. Nishikawa Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin J Clin Invest 91 1993 1608 1615
10. A.R. Ahmed, J.C. Maize, and T.T. Provost Bullous pemphigoid: clinical and immunologic follow-up after successful therapy Arch Dermatol 113 1977 1043 1046
11. D. Zillikens, A. Ambach, M. Schuessler, R. Dummer, A.A. Hartmann, and G. Burg The interleukin-2 receptor in lesions and serum of bullous pemphigoid Arch Dermatol Res 284 1992 141 145
12. H.H. Pas, M.C. de Jong, M.F. Jonkman, K. Heeres, I.J. Slijper-Pal, and J.B. van der Meer Bulllous pemphigoid: serum antibody titre and antigen specificity Exp Dermatol 4 1995 372 376
13. S. Hofmann, S. Thoma-Uszynski, T. Hunziker, P. Bernard, C. Koebnick, and A. Stauber Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain J Invest Dermatol 119 2002 1065 1073